Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance innovative medicines and vaccines across oncology, immunology, rare diseases, and more. The company gained worldwide recognition for its COVID-19 vaccine developed with BioNTech, a major contributor to pandemic response efforts. A key recent development is the positive Phase 3 topline data for Pfizer Inc. (NYSE:PFE ...